Kissei Pharmaceutical Co., Ltd.
Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.
-
New hope for endometriosis pain: phase 3 trial launched
Symptom relief OngoingThis study tests a new medicine called KLH-2109 to see if it works as well as a standard treatment (leuprorelin) for reducing pelvic pain in women with endometriosis. About 288 premenopausal women aged 18 and older with confirmed endometriosis will take part. The main goal is to …
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 07:41 UTC
-
New pill aims to smooth out Parkinson's motor ups and downs
Symptom relief OngoingThis study tests an experimental drug called KDT-3594 in 150 people with advanced Parkinson's disease who still have movement problems despite taking levodopa. Participants take the drug or a placebo daily for 17 weeks. The goal is to see if KDT-3594 can improve motor function an…
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC